-
Mar 1, 2021, 09:38 AM
by
John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.
Full story
-
Mar 1, 2021, 09:38 AM
by
SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
Full story
-
Mar 1, 2021, 09:34 AM
by
Full story
-
Mar 1, 2021, 09:34 AM
by
CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally.
Full story
-
Mar 1, 2021, 09:34 AM
by
In recent research at BIOTEC1 a three-step fragment-based screening of PfDHFR was undertaken employing Key Organics BIONET Premium library containing 1163 fragments. This library was chosen over other commercial ones as it is rule-of-three compliant and was curated from any PAINS and aggregating compounds. All fragments are also soluble at 200 mM in DMSO and display high diversity.
Full story
-
Mar 1, 2021, 09:32 AM
by
ComputaBio, a US supplier of computational biology services, claims to be a capable helping hand in drug design for industrial and academic scientists worldwide to expedite their drug development projects.
Full story
-
Mar 1, 2021, 09:32 AM
by
Full story
-
Mar 1, 2021, 09:32 AM
by
IntelyCare hires David Burke as chief financial officer to support the continued success and expansion of the company.
Full story
-
Mar 1, 2021, 09:32 AM
by
Full story
-
Mar 1, 2021, 09:32 AM
by
KROHNE, Inc. features its OPTIMASS 1000 Straight Tube Coriolis Mass Meter manufactured at its state of the art flow and level instrument manufacturing and calibration facility located in Beverly, MA. OPTIMASS 1000 is designed for exceptional measurement capabilities with the flexibility and options of high-end meters, at a competitive price. The OPTIMASS 1000 is well-suited for a variety of industries, including the chemical, petrochemical, food and beverage, water and pharmaceutical, and can operate reliably between -40 and 130° C.
Full story
-
Mar 1, 2021, 09:32 AM
by
Full story
-
Mar 1, 2021, 09:32 AM
by
KCR, the international clinical development solutions provider, today announced the establishment of a new branch in Sydney, Australia. The new location will enhance KCR’s regional coverage and maximize clinical capabilities for clients across the globe.
Full story
-
Mar 1, 2021, 09:32 AM
by
Full story
-
Mar 1, 2021, 09:28 AM
by
Purpose-built product is ideal for space-restricted and manufacturing floor IT installations
Full story
-
Mar 1, 2021, 09:28 AM
by
In the European project ENLIGHT, researchers from academic centers and leading industries across Europe are joining forces to develop a living model of the pancreas to enable better testing of diabetes medication.
Full story
-
Mar 1, 2021, 09:28 AM
by
Full story
-
Mar 1, 2021, 09:28 AM
by
CellPort Software today announced the launch of the CellPort Cell Culture Suite, a new cloud-based Software as a Service (SaaS) product focused on cell culture and cell banking. CellPort Cell Culture Suite is a secure, compliant SaaS-based application suite focused on managing all lab workflows, activities, equipment, materials, personnel, data/calculations, locations, and projects for cell culture and cell banking. CellPort reduces errors, increases reproducibility, enhances productivity, and provides full audit-ready traceability for regulated and unregulated environments.
Full story
-
Mar 1, 2021, 09:28 AM
by
Biocept presents data showing its Target Selector molecular assay kit detects mutations in up to 50% of tissue biopsy specimens, from patients diagnosed with non-small cell lung cancer, that were deemed quantity not sufficient (QNS).
Full story
-
Mar 1, 2021, 09:28 AM
by
Full story
-
Mar 1, 2021, 09:28 AM
by
Full story